Haer-Wigman Lonneke, van Zelst-Stams Wendy Ag, Pfundt Rolph, van den Born L Ingeborgh, Klaver Caroline Cw, Verheij Joke Bgm, Hoyng Carel B, Breuning Martijn H, Boon Camiel Jf, Kievit Anneke J, Verhoeven Virginie Jm, Pott Jan Wr, Sallevelt Suzanne Ceh, van Hagen Johanna M, Plomp Astrid S, Kroes Hester Y, Lelieveld Stefan H, Hehir-Kwa Jayne Y, Castelein Steven, Nelen Marcel, Scheffer Hans, Lugtenberg Dorien, Cremers Frans Pm, Hoefsloot Lies, Yntema Helger G
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute of Molecular Life Sciences, Nijmegen, The Netherlands.
Eur J Hum Genet. 2017 May;25(5):591-599. doi: 10.1038/ejhg.2017.9. Epub 2017 Feb 22.
Inherited eye disorders have a large clinical and genetic heterogeneity, which makes genetic diagnosis cumbersome. An exome-sequencing approach was developed in which data analysis was divided into two steps: the vision gene panel and exome analysis. In the vision gene panel analysis, variants in genes known to cause inherited eye disorders were assessed for pathogenicity. If no causative variants were detected and when the patient consented, the entire exome data was analyzed. A total of 266 Dutch patients with different types of inherited eye disorders, including inherited retinal dystrophies, cataract, developmental eye disorders and optic atrophy, were investigated. In the vision gene panel analysis (likely), causative variants were detected in 49% and in the exome analysis in an additional 2% of the patients. The highest detection rate of (likely) causative variants was in patients with inherited retinal dystrophies, for instance a yield of 63% in patients with retinitis pigmentosa. In patients with developmental eye defects, cataract and optic atrophy, the detection rate was 50, 33 and 17%, respectively. An exome-sequencing approach enables a genetic diagnosis in patients with different types of inherited eye disorders using one test. The exome approach has the same detection rate as targeted panel sequencing tests, but offers a number of advantages. For instance, the vision gene panel can be frequently and easily updated with additional (novel) eye disorder genes. Determination of the genetic diagnosis improved the clinical diagnosis, regarding the assessment of the inheritance pattern as well as future disease perspective.
遗传性眼病具有很大的临床和遗传异质性,这使得基因诊断变得繁琐。我们开发了一种外显子组测序方法,其中数据分析分为两个步骤:视觉基因panel分析和外显子组分析。在视觉基因panel分析中,评估已知会导致遗传性眼病的基因中的变异的致病性。如果未检测到致病变异且患者同意,则分析整个外显子组数据。总共对266名患有不同类型遗传性眼病的荷兰患者进行了研究,这些眼病包括遗传性视网膜营养不良、白内障、发育性眼病和视神经萎缩。在视觉基因panel分析中,49%的患者检测到(可能的)致病变异,在外显子组分析中,另有2%的患者检测到致病变异。(可能的)致病变异的最高检出率出现在遗传性视网膜营养不良患者中,例如色素性视网膜炎患者的检出率为63%。在发育性眼缺陷、白内障和视神经萎缩患者中,检出率分别为50%、33%和17%。外显子组测序方法能够通过一次检测对不同类型遗传性眼病患者进行基因诊断。外显子组方法与靶向panel测序检测具有相同的检出率,但具有许多优势。例如,视觉基因panel可以频繁且轻松地用额外的(新的)眼病基因进行更新。基因诊断的确定改善了临床诊断,包括对遗传模式的评估以及未来疾病的展望。